Not finding it? Sign in to also search OpenAlex live.
-
Abstract GS4-09: Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer: Primary Results from the POSITIVE Trial (IBCSG 48-14/BIG 8-13)2023 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Ann Partridge, Olivia Pagani, Samuel M. Niman, Monica Ruggeri, Fedro Alessandro Peccatori, Hatem A. Azim, +30 more
9citations -
Abstract OT1-04-02: POSITIVE: A study evaluating pregnancy, disease outcome and safety of interrupting endocrine therapy for premenopausal women with endocrine responsive breast cancer who desire pregnancy (IBCSG 48-14/big 8-13)2020 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Olivia Pagani, Ann H. Partridge, Fedro Alessandro Peccatori, Hatem A. Azim, Chikako Shimizu, Cristina Saura, +5 more
0citations -
Abstract GS02-11: Fertility preservation and assisted reproductive technologies (ART) in breast cancer (BC) patients (pts) interrupting endocrine therapy (ET) to attempt pregnancy
Hatem A. Azim, Samuel Niman, Ann H. Partridge, Isabelle Demeestere, Monica Ruggeri, Marco Angelo Colleoni, +29 more
1citations -
Switching between complement inhibitors in patients with PNH: A real-world analysis of strategy, efficacy, and safety.2025 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Morag Griffin, Bruno Fattizzo, Jong Wook Lee, Richard J. Kelly, Roochi Trikha, Yasutaka Ueda, +10 more
0citations -
Longer-term safety of pimicotinib in tenosynovial giant cell tumor (TGCT): Integrated analysis of phase 1 and phase 3 MANEUVER trial data.2026 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments
Hans A. J. Gelderblom, Vinod Ravi, Vishal Ghori, Aimar Zhang, Niki Karachaliou, Boyao Shan, +2 more
0citations -
P517 Re-treatment with filgotinib in patients with Ulcerative Colitis following treatment interruption: Analysis of the SELECTION and SELECTIONLTE studies2022 Journal of Crohn s and Colitis conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Severine A.R.A. Vermeire, Brian G. Feagan, Laurent Peyrin‐Biroulet, Alessandra Faria Oortwijn, Margaux Faes, Gerhard Rogler
2citations -
A phase I/II study of eribulin mesilate (ERI) plus irinotecan (IRI) in children with refractory or recurrent solid tumors.2020 Journal of Clinical Oncology conference-abstract Medicine Cancer Treatment and Pharmacology Open access
Michela Casanova, Christof Maria Kramm, Dirk Reinhardt, Franco Locatelli, David R. D’Adamo, Yan Jia, +6 more
2citations -
P47 Re-treatment with filgotinib in patients with ulcerative colitis following treatment interruption: SELECTION and SELECTIONLTE data2022 Poster presentations conference-abstract Biochemistry, Genetics and Molecular Biology Inflammatory Bowel Disease
Ben Morison, Severine Vermiere, Brian G. Feagan, Laurent Peyrin‐Biroulet, Alessandra Faria Oortwijn, Margaux Faes, +2 more
0citations -
Transform-1: A Randomized, Double-Blind, Placebo-Controlled, Multicenter, International Phase 3 Study of Navitoclax in Combination with Ruxolitinib Versus Ruxolitinib Plus Placebo in Patients with Untreated Myelofibrosis2023 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Naveen Pemmaraju, Adam J. Mead, Tim C. P. Somervaille, James K. McCloskey, Francesca Palandri, Steffen Koschmieder, +18 more
42citations -
Safety and efficacy of the mutant calreticulin-specific monoclonal antibody INCA033989 as monotherapy or in combination with ruxolitinib in patients (pts) with myelofibrosis (MF): Preliminary results from dose escalation of two global Phase 1 studies
John O Mascarenhas, Francesca Palandri, Raajit K. Rampal, Aaron Thomas Gerds, Andrew Charles Perkins, Bethan Psaila, +10 more
16citations -
Safety and efficacy of INCA033989, a novel first in class mutant calreticulin-specific monoclonal antibody, in patients with essential thrombocythemia2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Vikas Gupta, John O Mascarenhas, Haris Ali, David M. Ross, Abdulraheem Yacoub, Tania Jain, +27 more
12citations -
Overall survival and long-term safety with ripretinib vs sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: Final analyses from INTRIGUE.2024 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
John Raymond Zalcberg, Robin L. Jones, Jean‐Yves Blay, Suzanne George, Hans A. J. Gelderblom, Patrick Schöffski, +12 more
2citations -
Overall survival and long-term safety in patients with advanced gastrointestinal stromal tumor previously treated with imatinib: Updated analyses from INTRIGUE.2023 Journal of Clinical Oncology conference-abstract Medicine Gastrointestinal Tumor Research and Treatment
Robin L. Jones, Jean‐Yves Blay, Suzanne George, Hans A. J. Gelderblom, Patrick Schöffski, Margaret von Mehren, +12 more
1citations -
Abstract PS3-08-14: Typer—A randomized controlled trial evaluating the effect of typology-based coaching on therapy management for patients with hr+/her2- early breast cancer under adjuvant ribociclib treatment
M.K. Welslau, Christine Zeder-Göß, Renate Haidinger, Brigitte Welter, B. Aktas, P. Wimberger, +14 more
0citations -
Implementation of Continuous Pegasparaginase Dosing without an Asparaginase-Free Interval Reduces Hypersensitivity in Children with Newly Diagnosed Acute Lymphoblastic Leukemia: Results of the DCOG ALL11 Pegasparaginase Randomization
Leiah J. Brigitha, Rob Pieters, Marta F. Fiocco, Hester A. de Groot‐Kruseman, Marc Bierings, Cor van den Bos, +5 more
0citations -
Assessing the last “large scale fluvial modification” across the hyperarid Atacama Desert, northern Chile2024 conference-abstract Earth and Planetary Sciences Geological formations and processes Open access
Janek Walk, Joel Mohren, Ariane Binnie, Dominik Brill, Helmut Brückner, Viktor Schaubert, +2 more
0citations -
O-099 TEAD4 regulates trophectoderm differentiation upstream of CDX2 in human preimplantation embryos2021 Human Reproduction conference-abstract Biochemistry, Genetics and Molecular Biology Developmental Biology and Gene Regulation
Panagiotis Stamatiadis, Annekatrien Boel, Gwenny Cosemans, Filip Van Nieuwerburgh, Björn Menten, Petra De Sutter, +3 more
0citations -
Adverse events and their management in patients with tenosynovial giant cell tumor (TGCT) treated with pimicotinib, after longer-term follow-up from the global phase 3 MANEUVER trial.2026 Journal of Clinical Oncology conference-abstract Medicine Musculoskeletal synovial abnormalities and treatments Open access
Vinod Ravi, Vishal Ghori, Aimar Zhang, Niki Karachaliou, Hans A. J. Gelderblom, Qingping Zou, +2 more
0citations -
Final results from a prospective, multicenter, non-interventional study (BESREMi-PASS) on the safety of ropeginterferon alfa-2b in 229 patients with polycythemia vera2025 Blood conference-abstract Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Veronika Buxhofer‐Ausch, Andreas Reiter, Ciprian Tomuleasa, Albert Woelfler, Lino Lars Teichmann, Luminita Ocroteala, +7 more
0citations